Incidence of postoperative gallstone disease after antiobesity surgery: population-based study from Sweden

被引:44
作者
Jonas, Eduard [1 ]
Marsk, Richard [1 ]
Rasmussen, Finn [2 ]
Freedman, Jacob [1 ]
机构
[1] Danderyd Hosp, Dept Surg, Dept Clin Sci, Karolinska Inst, SE-18288 Stockholm, Sweden
[2] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Obesity; Antiobesity surgery; Gallstones; Gastric bypass; Restrictive surgery;
D O I
10.1016/j.soard.2009.03.221
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Patients who have undergone antiobesity surgery are at risk of developing gallstones postoperatively. The aim of the present study was to assess the incidence of symptomatic gallstone disease in patients who have undergone antiobesity surgery compared with that of the general population. Methods: We performed a population-based cohort study of antiobesity surgery in Sweden from 1980 to 2006. A total of 8901 patients who had undergone antiobesity surgery and had not previously been treated for gallstone disease were indentified from the Inpatient Care Register. For each subject, 10 controls matched for age and gender, were identified in the register of the total population (89,010). Censoring occurred at the end of the study (December 31, 2006), date of emigration, or date of death (9.1 +/- 6.6 years of follow-up). Results: The incidence of gallstone disease was 122.2/10,000 person-years in the surgical group compared with 22.2/10,000 person-years in the controls. The incidence of cholecystectomy was greater in the surgical group than in the controls (106.1 versus 19.5/10,000 person-years). The incidence ratio for gallstone disease was 5.5 (range 5.05.9) and for cholecystectomy was 5.4 (range 5.0-5.9). Conclusion: A fivefold increased risk of symptomatic gallstone disease was found after antiobesity surgery compared with that in the general population. (Surg Obes Relat Dis 2010;6:54-58.) (C) 2010 American Society for Metabolic and Bariatric Surgery. All rights reserved.
引用
收藏
页码:54 / 58
页数:5
相关论文
共 22 条
[1]   GALLBLADDER-DISEASE IN THE MORBIDLY OBESE [J].
AMARAL, JF ;
THOMPSON, WR .
AMERICAN JOURNAL OF SURGERY, 1985, 149 (04) :551-557
[2]  
Caruana Joseph A, 2005, Surg Obes Relat Dis, V1, P564, DOI 10.1016/j.soard.2005.08.004
[3]   Effect of estrogen therapy on gallbladder disease [J].
Cirillo, DJ ;
Wallace, RB ;
Rodabough, RJ ;
Greenland, P ;
LaCroix, AZ ;
Limacher, MC ;
Larson, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (03) :330-339
[4]   Improvement in co-morbidities following weight loss from gastric bypass surgery [J].
Dhabuwala, A ;
Cannan, RJ ;
Stubbs, RS .
OBESITY SURGERY, 2000, 10 (05) :428-435
[5]   Gallstones in obesity and weight loss [J].
Erlinger, S .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (12) :1347-1352
[6]  
Li VK, 2009, SURG ENDOSC
[7]   A rational approach to cholelithiasis in bariatric surgery - Its application to the laparoscopically placed adjustable gastric band [J].
O'Brien, PE ;
Dixon, JB .
ARCHIVES OF SURGERY, 2003, 138 (08) :908-912
[8]  
Patel KR, 2006, AM SURGEON, V72, P857
[9]  
Persson G, 2007, 2007 REP SWED NAT RE
[10]   Expectant management of the asymptomatic gallbladder at Roux-en-Y gastric bypass [J].
Portenier, Dana D. ;
Grant, John P. ;
Blackwood, Hilary S. ;
Pryor, Aurora ;
McMahon, Ross L. ;
DeMaria, Eric .
SURGERY FOR OBESITY AND RELATED DISEASES, 2007, 3 (04) :476-479